Fund Name | Location |
Al Serkal Group | Dubai, United Arab Emirates |
Aspen Highland Partners | - |
Brio Capital Management | New York, New York, United States |
Charles Hood Foundation | Boston, Massachusetts, United States |
China Fortune Securities | China, Guangdong, Shenzhen |
Cronus Ventures | Bellevue, United States, Washington |
Daum Communications | Cheju-do, Jeju, South Korea |
Horizon Group | - |
Kudelski Group | Cheseaux, Switzerland, Vaud |
OPTrust Private Markets Group | Canada, Ontario, Toronto |
Oscar Health | New York, New York, United States |
Patriot Financial Partners | Pennsylvania, Philadelphia, United States |
Sasken Communication Technologies | Bengaluru, India, Karnataka |
Studies | Japan, Tokyo |
The Phoenix Fund | Delhi, India, New Delhi |
Trancos Ventures | Illinois, Lincolnshire, United States |
Warburton Group | - |
Wikow Ventures | Hallands Lan, Kullavik, Sweden |
WS Ventures Management | Dallas, Texas, United States |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
CureGenetics | $60M | 05 Jan 2022 | Gusu District, Jiangsu, China | ||
Boan Biotech | $105M | 05 Jan 2021 | Yantai, Liaoning, China | ||
Huayin Health | $85M | 08 Apr 2020 | Yuexiu District, Guangdong Province, China | ||
Suzhou Ribo Life Science | $28M | 05 Dec 2019 | China, Anhui, China | ||
17 May 2018 | China, Beijing | ||||
Making Moves | $678K | 01 Feb 2017 | North Holland |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
CureGenetics | $60M | 05 Jan 2022 | Gusu District, Jiangsu, China | ||
Boan Biotech | $105M | 05 Jan 2021 | Yantai, Liaoning, China | ||
Huayin Health | $85M | 08 Apr 2020 | Yuexiu District, Guangdong Province, China | ||
Suzhou Ribo Life Science | $28M | 05 Dec 2019 | China, Anhui, China | ||
17 May 2018 | China, Beijing | ||||
Making Moves | $678K | 01 Feb 2017 | North Holland |